| Accession Number | 0001840706-26-000275 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 7, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Ordinary Shares | โ | Aug 5, 2026 | Exercise/Conversion | 3,000 | $3.28 | $9,840.00 | 603,887 | Direct | โ | View Details | |
Chief Scientific Officer | Ordinary Shares | โ | Aug 5, 2026 | Sale | 3,000 | $7.00 | $21,012.90 | 600,887 | Direct | โ | View Details | |
Chief Scientific Officer | Ordinary Shares | โ | Aug 7, 2026 | Exercise/Conversion | 7,000 | $3.28 | $22,960.00 | 607,887 | Direct | โ | View Details | |
Chief Scientific Officer | Ordinary Shares | โ | Aug 7, 2026 | Sale | 7,000 | $7.02 | $49,151.90 | 600,887 | Direct | โ | View Details | |
Chief Scientific Officer | Ordinary Shares | โ | Aug 7, 2026 | Sale | 10,000 | $7.48 | $74,759.00 | 590,887 | Direct | โ | View Details | |
Chief Scientific Officer | Share Option (Right to Buy) | Derivative | Aug 5, 2026 | Exercise/Conversion | 3,000 | $3.28 | $9,840.00 | 7,000 | Direct | โ | View Details | |
Chief Scientific Officer | Share Option (Right to Buy) | Derivative | Aug 7, 2026 | Exercise/Conversion | 7,000 | $3.28 | $22,960.00 | 0 | Direct | โ | View Details |